(Q51180087)
Statements
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine. (English)
1 reference
Robert Ikenberg
1 reference
Nadine Hertel
1 reference
R Andrew Moore
1 reference
Marko Obradovic
1 reference
Garth Baxter
1 reference
Pete Conway
1 reference
Hiltrud Liedgens
1 reference
28 March 2012
1 reference
15
1 reference
4
1 reference
724-736
1 reference